Both in Lab Analytical Instruments
908 Devices vs Harvard Bioscience
Over the past year MASS returned +38.0% and HBIO returned +52.4%; their daily moves had a correlation of 0.05.
MASS +38.0% HBIO +52.4%Growth of $1, one year, split-adjusted
| Metric | MASS | HBIO |
|---|---|---|
| Price | $10.95 | $8.75 |
| Market cap | $452.4M | $39.8M |
| Today | +2.58% | +0.92% |
| 1 month | −11.2% | +2.2% |
| 6 months | +35.8% | +20.9% |
| Year to date | +108.5% | +30.8% |
| 1 year | +38.0% | +52.4% |
| Revenue growth (YoY) | +23.3% | +11.1% |
| Gross margin | 51.9% | 55.6% |
| Net margin | −74.0% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 7.4× | 0.5× |
| Net cash | $101.5M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 59.5% | 35.0% |
| Short % of float | 8.7% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).